Madrigal Pharmaceuticals MDGL
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 582.34 | 603 | -9.54 | -59 | -4.47 | 1,260 |
| 2025Q3 | 458.66 | 626 | -17.28 | -114 | -9.60 | 1,362 |
| 2025Q2 | 302.64 | 696 | -6.01 | -42 | -4.20 | 1,015 |
| 2025Q1 | 331.23 | 711 | -10.00 | -73 | -7.18 | 997 |
| 2024Q4 | 308.57 | 754 | -7.76 | -59 | -5.62 | 1,042 |
| 2024Q3 | 212.22 | 777 | -13.09 | -107 | -9.84 | 1,073 |
| 2024Q2 | 280.16 | 857 | -17.80 | -152 | -13.93 | 1,100 |
| 2024Q1 | 267.04 | 851 | -23.49 | -148 | -17.13 | 1,082 |
| 2023Q4 | 231.38 | 405 | -52.48 | -112 | -25.54 | 641 |
| 2023Q3 | 146.04 | 22 | -157.04 | -99 | -36.54 | 238 |
| 2023Q2 | 231.00 | 104 | -67.65 | -86 | -27.03 | 302 |
| 2023Q1 | 242.26 | 150 | -44.25 | -77 | -22.13 | 332 |
| 2022Q4 | 290.25 | 197 | -82.58 | -86 | -32.96 | 363 |
| 2022Q3 | 64.99 | 11 | -172.38 | -81 | -43.30 | 159 |
| 2022Q2 | 71.58 | 84 | -61.70 | -71 | -32.22 | 216 |
| 2022Q1 | 98.12 | 146 | -33.65 | -58 | -23.19 | 223 |
| 2021Q4 | 84.74 | 196 | -29.95 | -65 | -22.33 | 273 |
| 2021Q3 | 79.79 | 235 | -24.96 | -63 | -19.95 | 305 |
| 2021Q2 | 97.41 | 271 | -23.21 | -62 | -19.34 | 328 |
| 2021Q1 | 116.97 | 261 | -21.00 | -53 | -17.61 | 310 |